Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 13220 participants.
Also called NCT01076764
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 13,220 participants
- Sponsor
- Registry
-
NCT01076764 -
2009-016568-36
-
- Main results
- Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial
- Other papers using this trial's data
- Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial
- Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czechia, Egypt, Estonia, France, Germany, Greece, Hong Kong SAR China, Hungary, India, Indonesia, Israel, Italy, Jordan, Latvia, Lebanon, Lithuania, Malaysia, Mexico, Montenegro, Netherlands, New Zealand, North Macedonia, Norway, Panama, Peru, Poland, Portugal, Romania, Russia, Serbia, Singapore, Slovakia, South Africa, South Korea, Spain, Switzerland, Taiwan, Thailand, Tunisia, Türkiye, Ukraine, United Kingdom, Vietnam
- Registry status
- Completed
Technical summary
Registry record NCT01076764. Randomized; triple masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2013-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
- Acronym
- TAO
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Otamixaban
- Intervention (Drug)
- Placebo (for Otamixaban)
- Intervention (Drug)
- UFH
- Intervention (Drug)
- Placebo (for UFH)
- Intervention (Drug)
- Eptifibatide
- Intervention (Drug)
- Placebo (for Eptifibatide)
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01076764- Content hash
a6dad61f669819a95598bdc2047331ae9887950b3f5ac43beb4238893971a315